Vironexis
Vironexis Biotherapeutics
United States · $26.0M raised
- Business Model
- B2B
- Website
- vironexis.com
- Total Funding
- $26.0M
- Last Round
- $26.0M SeedJul 2024
- Rounds
- 1
About
Vironexis Biotherapeutics is a clinical-stage biotech developing AAV-delivered T-cell immunotherapy for cancer treatment.
Summary
Vironexis is a Biotech company based in United States. It has raised $26.0M in total across 1 round, most recently a $26.0M Seed round in Jul 2024. Investors include Drive Capital, Future Ventures and Ensemble VC.
Tech & App Stack
3 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jul 2024
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company